FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1234806008: Observation using immunohistochemistry (observable entity)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 30-Sep 2022. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
5084064014 Observation using immunohistochemistry (observable entity) en Fully specified name Active Entire term case insensitive SNOMED CT core module
5091341019 Observation using immunohistochemistry en Synonym Active Entire term case insensitive SNOMED CT core module

39 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Observation using immunohistochemistry Is a Observable entity true Inferred relationship Existential restriction modifier
Observation using immunohistochemistry Technique Immunohistochemistry technique true Inferred relationship Existential restriction modifier 1
Inbound Relationships Type Active Source Characteristic Refinability Group
Status of estrogen receptor stain in control cells by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Status of progesterone receptor stain in control cells by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of progesterone receptor in primary malignant neoplasm of breast by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of estrogen receptor in primary malignant neoplasm of breast by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm of breast by immunohistochemistry Is a False Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Percent of cells with progesterone receptor in primary malignant neoplasm of breast by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Percent of cells with estrogen receptor in primary malignant neoplasm of breast by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of receptor tyrosine-protein kinase erbB-2 in primary malignant neoplasm of breast by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of colon by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of colon by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of ALK tyrosine kinase receptor in primary malignant neoplasm of lung by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of proto-oncogene tyrosine-protein kinase ROS in primary malignant neoplasm of lung by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of endometrium by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of endometrium by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of estrogen receptor in primary malignant neoplasm of endometrium by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of receptor tyrosine-protein kinase erbB-2 in primary malignant neoplasm of endometrium by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of progesterone receptor in primary malignant neoplasm of endometrium by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of endometrium by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of lung by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of lung by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of mismatch repair endonuclease PMS2 in primary malignant neoplasm of colon by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of lung by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of DNA mismatch repair protein Mlh1 in primary malignant neoplasm of colon by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of programmed cell death 1 ligand 1 in primary malignant neoplasm of lung by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of DNA mismatch repair protein Msh2 in primary malignant neoplasm of endometrium by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of DNA mismatch repair protein Msh6 in primary malignant neoplasm of lung by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of receptor tyrosine-protein kinase erbB-2 in primary malignant neoplasm of lung by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Percent of cell nuclei positive for proliferation marker protein Ki-67 in primary malignant neoplasm by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of anoctamin-1 in primary gastrointestinal stromal sarcoma by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of mast/stem cell growth factor receptor Kit in primary gastrointestinal stromal sarcoma by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial in primary gastrointestinal stromal sarcoma by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier
Presence of succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial in primary gastrointestinal stromal sarcoma by immunohistochemistry Is a True Observation using immunohistochemistry Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start